Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,774,592
  • Shares Outstanding, K 536,376
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.60
  • Price/Sales 5.21
  • Price/Cash Flow 10.49
  • Price/Book 23.73
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 32.16% ( +1.01%)
  • Historical Volatility 19.10%
  • IV Percentile 98%
  • IV Rank 94.49%
  • IV High 33.07% on 04/16/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.88
  • Today's Volume 29,760
  • Volume Avg (30-Day) 10,855
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 176,194
  • Open Int (30-Day) 181,802

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 3.76
  • Number of Estimates 12
  • High Estimate 4.06
  • Low Estimate 3.32
  • Prior Year 3.98
  • Growth Rate Est. (year over year) -5.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.68 +6.79%
on 04/19/24
279.84 -0.52%
on 05/01/24
+2.18 (+0.79%)
since 04/02/24
3-Month
260.68 +6.79%
on 04/19/24
329.72 -15.57%
on 02/05/24
-44.80 (-13.86%)
since 02/02/24
52-Week
211.71 +31.50%
on 06/01/23
329.72 -15.57%
on 02/05/24
+42.42 (+17.98%)
since 05/02/23

Most Recent Stories

More News
Amgen: Q1 Earnings Snapshot

Amgen: Q1 Earnings Snapshot

AMGN : 278.39 (+0.37%)
TSX Wobbles at Thursday Open

Equities in Toronto waned at the open, despite a surge in technology shares, as positive comments ...

AMGN : 278.39 (+0.37%)
Stocks Climb Before the Open After Fed Decision, Apple Earnings on Tap

June S&P 500 E-Mini futures (ESM24) are up +0.58%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.77% this morning after Federal Reserve Chair Jerome Powell appeared to rule out the possibility of...

ESM24 : 5,108.75 (+0.34%)
NQM24 : 17,762.50 (+0.64%)
CVS : 55.15 (-2.06%)
SBUX : 74.93 (+0.66%)
AMD : 146.16 (+1.31%)
TECH : 75.60 (+2.91%)
AMZN : 184.72 (+3.20%)
AAPL : 173.03 (+2.20%)
COP : 122.25 (-1.68%)
AMGN : 278.39 (+0.37%)
BKNG : 3,472.91 (+1.68%)
FTNT : 65.20 (+2.63%)
Options Watchlist: 10 Stocks Showing High IV Percentile

IV Percentile is a measure of implied volatility where current implied volatility is compared to the past implied volatility range.

DELL : 123.39 (+3.88%)
EMR : 106.41 (-0.04%)
PANW : 295.32 (+2.78%)
ZTS : 167.23 (+5.51%)
FTNT : 65.20 (+2.63%)
SBUX : 74.93 (+0.66%)
AMGN : 278.39 (+0.37%)
AMD : 146.16 (+1.31%)
AMZN : 184.72 (+3.20%)
QCOM : 180.10 (+9.74%)
Is Amgen Stock a Buy for Its 3% Yield?

Amgen’s stock offers investors a yield slightly above 3%, supported by 12 years of consistent growth. Despite a 6% year-to-date decline, the stock is rated as a moderate buy with a potential 12% upside...

AMGN : 278.39 (+0.37%)
$SPX : 5,064.20 (+0.91%)
GS : 432.57 (+1.32%)
Stocks Set to Open Higher as Investors Await U.S. Jobs Data and More Big Tech Earnings, Fed Meeting on Tap

June S&P 500 E-Mini futures (ESM24) are up +0.19%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.28% this morning as investors looked ahead to earnings reports from some of the world’s most prominent...

ESM24 : 5,108.75 (+0.34%)
NQM24 : 17,762.50 (+0.64%)
GOOGL : 166.62 (+1.68%)
RMD : 218.15 (+1.46%)
MSFT : 397.84 (+0.73%)
INTC : 30.51 (+0.46%)
AAPL : 173.03 (+2.20%)
AMZN : 184.72 (+3.20%)
AMD : 146.16 (+1.31%)
QCOM : 180.10 (+9.74%)
KO : 61.99 (+0.10%)
MCD : 273.28 (-0.42%)
Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

LLY : 755.91 (-2.68%)
NVO : 124.02 (-4.02%)
NVDA : 858.17 (+3.34%)
AMGN : 278.39 (+0.37%)
PFE : 27.70 (+1.91%)
VKTX : 75.76 (-0.88%)
1 No-Brainer Vanguard Fund to Buy Right Now

This Vanguard growth fund is home to some of the world's most innovative companies.

VOO : 464.22 (+0.93%)
META : 441.68 (+0.57%)
MSFT : 397.84 (+0.73%)
AAPL : 173.03 (+2.20%)
AMZN : 184.72 (+3.20%)
NVDA : 858.17 (+3.34%)
AMGN : 278.39 (+0.37%)
ADBE : 476.57 (+1.53%)
VKTX : 75.76 (-0.88%)
PFE : 27.70 (+1.91%)
ANET : 261.86 (+2.61%)
PLTR : 22.55 (+1.94%)
Can This High-Yield Dividend Stock Keep Beating the S&P 500?

Amgen's shares have come under pressure this year, making it a compelling bargain buy.

AMGN : 278.39 (+0.37%)
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

Not every business in operation today is built to thrive -- or even last -- indefinitely. These are.

BRK.AX : 0.013 (-7.14%)
BA : 178.85 (+4.31%)
DAL : 51.03 (+2.02%)
AMGN : 278.39 (+0.37%)
BRK-A : N/A (N/A)
BRK-B : N/A (N/A)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 283.44
2nd Resistance Point 281.04
1st Resistance Point 279.71
Last Price 278.39
1st Support Level 275.98
2nd Support Level 273.58
3rd Support Level 272.25

See More

52-Week High 329.72
Fibonacci 61.8% 284.64
Last Price 278.39
Fibonacci 50% 270.71
Fibonacci 38.2% 256.79
52-Week Low 211.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar